UNCY•benzinga•
Unicycive Therapeutics FY 2024 GAAP EPS $(0.56) Misses $(0.50) Estimate, As Of December 31, 2024, Cash And Cash Equivalents Of $26.1M, Sufficient To Fund Planned Operations Into 2026
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 31, 2025 by benzinga